INSIGHTS ON LIQUID DOSE MANUFACTURING
-
Navigating The New USP Chapter <382> For Elastomeric Closures
Dive into the scope of <382> for pharmaceutical closures and the regulatory landscape, which includes new required tests, instrumentation for compliance, and recommendations on implementation.
-
Isolated GENiSYS C Fill-Finish System: Available For Quick Delivery
Accelerate your parenteral drug production with a fully integrated, isolator-based fill-finish system. Compact design, rapid delivery, and maximum yield for agile drug development.
-
The Fill/Finish Timeline: What Comes After Manufacturing
The post-manufacturing backend of sterile injectable fill-finish operates in a strict sequence—encompassing inspection, testing, QA review, and complex labeling validation—requiring early planning to avoid timeline delays.
-
The Importance Of Tube Welding In Aseptic Bioprocessing
Sensitive biologics rely on aseptic processing and single‑use systems, making dependable sterile connections essential. See how tube welding offers a reliable way to reduce contamination.
-
Empowering Innovation: Harnessing CDMO Potential For Sterile Injectables10/20/2025
Specialized CDMOs are essential for meeting the growing demand and complex quality requirements for sterile injectables. Outsourcing provides crucial benefits like cost savings, flexibility, and a strategic focus on core competencies.
-
Compressed Gas Contamination: Guidelines For Control In Aseptic Manufacturing10/18/2024
Explore key guidelines for preserving the purity and quality of compressed gas, with an emphasis on contaminants, monitoring, and preventive maintenance practices.
-
Enable Low Volume Delivery Of Proteins In Aqueous Solutions11/7/2025
Achieve ultra-low volume dispensing of proteins and aqueous solutions without surfactants with consistent precision, minimal contamination, and broad compatibility to streamline your lab workflow.
-
Solve ATMP Aseptic Filling Challenges With Gloveless Isolators1/9/2026
Human intervention is the top contamination risk in ATMP manufacturing. Robotic gloveless isolators address that risk through full automation and real-time monitoring during aseptic filling.
-
Enhancing Biological Indicators With Enzyme Indicators6/30/2026
Achieve greater process assurance in decontamination cycles. Combining traditional indicators with rapid, quantitative enzyme data reveals performance trends to optimize validation.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
The Aseptic Filling Isolator is a custom-designed cGMP Class A/ISO 5 isolator system specifically designed for batch scale pharmaceutical production of injectable products for pre-clinical and clinical trial studies.
-
Discover a flexible, automation-ready microplate washer with precise control for ELISA, cell-based, and protein array assays that offers low-residue washing, regulatory compliance, and modular upgrades.
-
Used IMA cartoner, model IC150C, speeds up to 120 cartoners/minute, designed for pre glued cartons, 28 mm wide x 12 mm high x 55 mm long minimum carton size, 92 mm wide x 60 mm high x 190 mm long maximum carton size, with blister feeder, with leaflet inserter, Allen Bradley Micrologix 1500 plc with Panelview 550 HMI, Machine# B-92-024, built 2005.
-
Themo Scientific™ Nunc™ Cell Factory™ multi-layer systems are designed for a variety of biological and commercial applications. With a certified Sterility Assurance Level of 10-6 achieved following AAMI/ISO 11137-2-2006 guidelines and Nunclon™ Delta surface treatment, you can be assured of consistent performance from layer to layer and lot to lot. Our cell culture certification includes verification of monolayer formation and cloning efficiency using three cell lines and one primary cell.
-
Ensure unmatched purity across your process lines. Discover how cGMP-manufactured WFI quality water supports critical formulation, buffer prep, and cleaning workflows.